Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Engaging the medical mind: Does interactivity improve recall?
Recall matters when it comes to medical content. Find out how knowledge can be better retained through interactive medical education.
Read more
Pharma in Ireland
The Irish pharmaceutical sector is expanding. Read more about what is driving companies to channel investment into the Emerald Isle.
The curious paradox in cardiovascular disease
To mark World Heart Day 2023, how can the industry strike a balance between driving innovation and ensuring access to care for all?
How to satisfy the curious key opinion leader
How can companies best leverage their KOLs earlier in the product lifecycle, and how do KOLs themselves want to involved?
Should sales be a ‘dirty’ word in medical affairs?
Medical affairs and sales teams have distinctly different roles, but aren’t they just two planets orbiting the same sun?
Catching the ever elusive insight
How can medical affairs achieve efficiencies by standardising and modernising its insight gathering processes?
Staying out of hot water on social media
As the UK PMCPA publishes its first social media guidance for pharmaceutical companies, what can they do to avoid traps when it comes to posting online?
Going for gold in gynaecological cancers
The pharmaceutical industry is being urged to take action to bridge the access gap for women with gynaecological cancers, but what steps are needed to change the game?
CSL Behring’s Karen Pinachyan on the future of healthcare
Karen Pinachyan, Head of Medical Affairs for Europe, CSL Behring, talks to Isabel O’Brien about the power of personalised medicine, overhauling healthcare and why it is key to know your own mind
Loading posts...
« Previous
1
…
3
4
5
6
7
…
32
Next »